Computational identification of cross-reactive TCR epitopes with ARDitox
Cellular immunotherapies, such as those utilizing T lymphocytes expressing native or engineered T cell receptors (TCRs), have demonstrated therapeutic efficacy. However, some engineered high-affinity TCRs have caused fatal off-target immunotoxicity due to targeting epitopes later found to be express...
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
01 November 2025
|
| In: |
Journal of cancer research and clinical oncology
Year: 2025, Volume: 151, Issue: 12, Pages: 1-15 |
| ISSN: | 1432-1335 |
| DOI: | 10.1007/s00432-025-06330-7 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s00432-025-06330-7 |
| Author Notes: | Victor Murcia Pienkowski, Tamara Boschert, Piotr Skoczylas, Anna Sanecka-Duin, Maciej Jasiński, Bartłomiej Król-Józaga, Giovanni Mazzocco, Sławomir Stachura, Lukas Bunse, Jan Kaczmarczyk, Edward W. Green, Agnieszka Blum |
| Summary: | Cellular immunotherapies, such as those utilizing T lymphocytes expressing native or engineered T cell receptors (TCRs), have demonstrated therapeutic efficacy. However, some engineered high-affinity TCRs have caused fatal off-target immunotoxicity due to targeting epitopes later found to be expressed by both tumor cells and healthy tissues. Unfortunately, TCRs can be cross-reactive to epitopes with highly distinct sequences, making prediction difficult, and the exquisite sequence specificity of TCRs means that safety studies in mice miss human-specific epitopes. |
|---|---|
| Item Description: | Gesehen am 09.12.2025 |
| Physical Description: | Online Resource |
| ISSN: | 1432-1335 |
| DOI: | 10.1007/s00432-025-06330-7 |